This report contains market size and forecasts of Prostate Cancer Diagnostics and Therapy in Global, including the following market information:
Global Prostate Cancer Diagnostics and Therapy Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnostics and Therapy market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Androgen Receptor-Directed Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnostics and Therapy include Ipsen SA, Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Abbvie Inc., Merck & Co. Inc., AstraZeneca PLC, Thermo Fisher Scientific and Dendreon Pharmaceuticals LLC, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnostics and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics and Therapy Market, by Treatment Method, 2018-2023, 2023-2030 ($ millions)
Global Prostate Cancer Diagnostics and Therapy Market Segment Percentages, by Treatment Method, 2022 (%)
Androgen Receptor-Directed Therapy
Taxane-Based Chemotherapy
Global Prostate Cancer Diagnostics and Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Prostate Cancer Diagnostics and Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Prostate Cancer Diagnostics and Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Prostate Cancer Diagnostics and Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnostics and Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnostics and Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ipsen SA
Pfizer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Abbvie Inc.
Merck & Co. Inc.
AstraZeneca PLC
Thermo Fisher Scientific
Dendreon Pharmaceuticals LLC
F. Hoffmann-La Roche Ltd
Hologic Inc.
Astellas Pharma Inc.
Koninklijke Philips NV
Sanofi-Aventis
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Treatment Method
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnostics and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnostics and Therapy Overall Market Size
2.1 Global Prostate Cancer Diagnostics and Therapy Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Diagnostics and Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics and Therapy Players in Global Market
3.2 Top Global Prostate Cancer Diagnostics and Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnostics and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics and Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnostics and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Treatment Method - Global Prostate Cancer Diagnostics and Therapy Market Size Markets, 2022 & 2030
4.1.2 Androgen Receptor-Directed Therapy
4.1.3 Taxane-Based Chemotherapy
4.2 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
4.2.1 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
4.2.2 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue, 2023-2030
4.2.3 By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue, 2023-2030
5.2.3 By Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnostics and Therapy Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue, 2023-2030
6.2.3 By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.3.2 US Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.3 France Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.5.2 China Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.5.6 India Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Diagnostics and Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Ipsen SA
7.1.1 Ipsen SA Corporate Summary
7.1.2 Ipsen SA Business Overview
7.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.1.4 Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.1.5 Ipsen SA Key News
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Corporate Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.2.4 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News
7.3 Johnson & Johnson Services Inc.
7.3.1 Johnson & Johnson Services Inc. Corporate Summary
7.3.2 Johnson & Johnson Services Inc. Business Overview
7.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.3.4 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Services Inc. Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.4.4 Bayer AG Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer AG Key News
7.5 Abbvie Inc.
7.5.1 Abbvie Inc. Corporate Summary
7.5.2 Abbvie Inc. Business Overview
7.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.5.4 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.5.5 Abbvie Inc. Key News
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Corporate Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.6.4 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.6.5 Merck & Co. Inc. Key News
7.7 AstraZeneca PLC
7.7.1 AstraZeneca PLC Corporate Summary
7.7.2 AstraZeneca PLC Business Overview
7.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.7.4 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca PLC Key News
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporate Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.8.4 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific Key News
7.9 Dendreon Pharmaceuticals LLC
7.9.1 Dendreon Pharmaceuticals LLC Corporate Summary
7.9.2 Dendreon Pharmaceuticals LLC Business Overview
7.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.9.4 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.9.5 Dendreon Pharmaceuticals LLC Key News
7.10 F. Hoffmann-La Roche Ltd
7.10.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.10.2 F. Hoffmann-La Roche Ltd Business Overview
7.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd Key News
7.11 Hologic Inc.
7.11.1 Hologic Inc. Corporate Summary
7.11.2 Hologic Inc. Business Overview
7.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.11.4 Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.11.5 Hologic Inc. Key News
7.12 Astellas Pharma Inc.
7.12.1 Astellas Pharma Inc. Corporate Summary
7.12.2 Astellas Pharma Inc. Business Overview
7.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.12.4 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.12.5 Astellas Pharma Inc. Key News
7.13 Koninklijke Philips NV
7.13.1 Koninklijke Philips NV Corporate Summary
7.13.2 Koninklijke Philips NV Business Overview
7.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.13.4 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.13.5 Koninklijke Philips NV Key News
7.14 Sanofi-Aventis
7.14.1 Sanofi-Aventis Corporate Summary
7.14.2 Sanofi-Aventis Business Overview
7.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Major Product Offerings
7.14.4 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue in Global Market (2018-2023)
7.14.5 Sanofi-Aventis Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnostics and Therapy Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnostics and Therapy Market Drivers in Global Market
Table 3. Prostate Cancer Diagnostics and Therapy Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnostics and Therapy in Global Market
Table 5. Top Prostate Cancer Diagnostics and Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnostics and Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnostics and Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnostics and Therapy Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnostics and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnostics and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Treatment Method ? Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Treatment Method - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Treatment Method - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnostics and Therapy Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2023-2030
Table 30. Ipsen SA Corporate Summary
Table 31. Ipsen SA Prostate Cancer Diagnostics and Therapy Product Offerings
Table 32. Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Pfizer Inc. Corporate Summary
Table 34. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 35. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 36. Johnson & Johnson Services Inc. Corporate Summary
Table 37. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 38. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 39. Bayer AG Corporate Summary
Table 40. Bayer AG Prostate Cancer Diagnostics and Therapy Product Offerings
Table 41. Bayer AG Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 42. Abbvie Inc. Corporate Summary
Table 43. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 44. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 45. Merck & Co. Inc. Corporate Summary
Table 46. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 47. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 48. AstraZeneca PLC Corporate Summary
Table 49. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product Offerings
Table 50. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Thermo Fisher Scientific Corporate Summary
Table 52. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product Offerings
Table 53. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Dendreon Pharmaceuticals LLC Corporate Summary
Table 55. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product Offerings
Table 56. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 57. F. Hoffmann-La Roche Ltd Corporate Summary
Table 58. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product Offerings
Table 59. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 60. Hologic Inc. Corporate Summary
Table 61. Hologic Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 62. Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 63. Astellas Pharma Inc. Corporate Summary
Table 64. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product Offerings
Table 65. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 66. Koninklijke Philips NV Corporate Summary
Table 67. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product Offerings
Table 68. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
Table 69. Sanofi-Aventis Corporate Summary
Table 70. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product Offerings
Table 71. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Prostate Cancer Diagnostics and Therapy Segment by Treatment Method in 2022
Figure 2. Prostate Cancer Diagnostics and Therapy Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnostics and Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnostics and Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnostics and Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue in 2022
Figure 8. By Treatment Method - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 10. By Region - Global Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 11. By Country - North America Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 12. US Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 16. Germany Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. France Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 24. China Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 28. India Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 30. Brazil Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnostics and Therapy Revenue Market Share, 2018-2030
Figure 33. Turkey Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Prostate Cancer Diagnostics and Therapy Revenue, (US$, Mn), 2018-2030
Figure 37. Ipsen SA Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Bayer AG Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hologic Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
